Redhill Biopharma Ltd. (RDHL) Social Stream

Redhill Biopharma Ltd. (RDHL): $0.44

0.01 (-2.12%)

POWR Rating

Component Grades








Featured Post From StockTwits About RDHL

$RDHL So the global 475-patient study is completed as we know. 57 study locations in 10 countries:

UK, Russia, UK, Brazil, Peru, Italy, Mexico, Israel, Poland, Colombia.

I wonder what is the % of different covid variants among those patients? I certain that opaganib wll prove to be effective, what I wonder is, will this P3 be able to showcase efficacy against all concerning variants.

As we do not know how many Delta or Lambda or Colombian variants are there among those 475 patients I guess we can just wait for the results. I think at least Delta (UK, US, Russia) and Lambda (Peru, Colombia, Mexico) should be well covered by this study. Any thoughts on this?
BestBiotechNow, published August 7, 2021

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!